# Neonatal Jaundice, Hypoglycaemia and Seizures for NEET PG Paediatrics: Kramer Zones, Phototherapy, Glucose Rules and the ICMR Seizure Ladder

Source: https://tracknation.in/story/neonatal-jaundice-hypoglycaemia-and-seizures-for-neet-pg-paediatrics-kramer-zones-phototherapy-glucose-rules-and-the-icmr-seizure-ladder (TrackNation — free UPSC notes with PYQs)

> NEET PG Paediatrics: physiological vs pathological jaundice, breastfeeding and breast-milk jaundice, Kramer zones, ICMR serious jaundice, phototherapy and exchange rules; neonatal hypoglycaemia screening, < 45 mg/dL, bolus and GIR; neonatal seizure types and the ICMR drug ladder, with a jaundice chart, hooks, MCQs and cards.

## Start Here

🎯 **Exam priority: Very high.** *Expect: physiological vs pathological jaundice by timing, breastfeeding vs breast-milk jaundice,
Kramer zones, what makes jaundice "serious", phototherapy wavelength and don'ts, exchange volume, the hypoglycaemia cut-off and bolus, GIR, and the
order of drugs in neonatal seizures.*

CBME mapping: **PE19**. Fact-checked against ICMR Standard Treatment Workflows (Neonatal Jaundice, Neonatal Hypoglycemia, Neonatal Seizures,
2020) and the MSD Manual.

*Kramer zones, when each type of jaundice appears, serious jaundice and treatment rules. Drawn by TrackNation.*

## Why Newborns Turn Yellow (MSD)

- Almost all early neonatal jaundice is **unconjugated**. **Physiological** causes: shorter red-cell life span (more bilirubin), low
**UGT** activity (less conjugation) and more **enterohepatic circulation**. It appears after 2–3 days and resolves within about a week.

- **Pathological** until proved otherwise: jaundice in the **first 24–48 hours** or lasting **> 2 weeks**.

- **Breastfeeding jaundice**: in about one in six breastfed babies, in the **first week**, from **low milk intake** — prevented by
**more frequent feeds**. **Human-milk (breast-milk) jaundice**: starts **after 5–7 days**, peaks about **2 weeks**, linked to
**beta-glucuronidase** in milk.

- Only unconjugated bilirubin causes **chronic bilirubin encephalopathy** (formerly kernicterus). Conjugated jaundice points to cholestasis —
phototherapy does not help it.

## Jaundice: Assess and Treat (ICMR)

- **Risk factors**: gestation < 38 weeks, a sibling who needed treatment, ABO/Rh incompatibility, G6PD-prevalent area, exclusive breastfeeding
with weight loss > 3%/day or > 10% total, high-risk-zone bilirubin.

- **Kramer zones** (daylight, naked baby, blanched skin, every 12 h for 3–5 days): face/neck ≈ 4–6; chest ≈ 8–10; lower abdomen/thighs ≈ 12–14;
limbs ≈ 15–18; palms/soles > 15–20 mg/dL.

- **Serious jaundice** → start **intensive phototherapy** at once: visible in the **first 24 h**, **yellow palms and soles**,
or signs of acute bilirubin encephalopathy (poor feeding, lethargy, hypotonia, arching, retrocollis, opisthotonus, convulsion, high-pitched cry).
Measure TSB if jaundice in the first 24 h or > 12–14 mg/dL visually after 24 h.

- **Phototherapy**: naked with eye cover and nappy, close to the lights, feeds allowed; **blue light 425–475 nm** works best (MSD). Repeat TSB
6–8-hourly in haemolysis, 12–24-hourly otherwise; **stop** when TSB falls below 13–14 mg/dL or 2 below the cut-off.

- **Exchange transfusion**: at once for encephalopathy or TSB above the cut-off; volume = **twice the blood volume (80–100 mL/kg)**.
Work-up: blood group and DCT, G6PD, smear and reticulocytes.

- **Never**: sunlight, phenobarbitone, stopping breastfeeding, or trusting visual/TcB readings under phototherapy. Avoid naphthalene balls.
Discharged before 72 h → review at 48–72 h.

## Neonatal Hypoglycaemia (ICMR)

- **Screen**: preterm, LBW, SGA, LGA, **infant of diabetic mother**, sick babies, after exchange, on IV fluids — at **2, 6, 12, 24, 48 and 72 hours**.
**Do not** screen healthy term AGA babies.

- **Cut-off: blood glucose < 45 mg/dL**. Signs: lethargy, limpness, jitteriness, convulsions, apnoea or cyanosis, weak high-pitched cry, poor feeding.

- **Asymptomatic**: supervised feed (breast or measured EBM), recheck in 1 hour; IV glucose if still < 45 or symptoms appear.
**Symptomatic or < 20 mg/dL**: **2 mL/kg of 10% dextrose IV**, then infusion at **GIR 6 mg/kg/min**, rising by 2 up to 12.

- **Refractory**: GIR > 12 for 24 h or need > 7 days → hydrocortisone 5 mg/kg/day (others: diazoxide, glucagon, octreotide) and refer.
Never feed dextrose instead of milk; avoid > 12.5–15% dextrose in a peripheral vein.

- Causes (MSD): low glycogen stores, delayed feeding, **hyperinsulinism** (diabetic mother, Beckwith–Wiedemann). Both symptomatic and
asymptomatic hypoglycaemia can cause permanent brain damage.

## Neonatal Seizures (ICMR)

- **At risk**: asphyxia, sepsis, meningitis, preterm, SGA, metabolic disturbance, major bleeding.

- Often **subtle**: pedalling, rowing or cycling limbs; lip pouting, mouthing, repeated sucking; vacant stare, eye deviation, nystagmoid
movements; unexplained apnoea or swings in heart rate.

- **Investigate all**: glucose, electrolytes, ionised calcium, blood count, renal and liver tests, blood gas, cranial ultrasound; CSF if sepsis is suspected; EEG.

- **Ladder**: TABC + IV line → glucose < 45? **2 mL/kg 10% dextrose** → **2 mL/kg 10% calcium gluconate** (diluted, over 10 min, on a monitor) →
**phenobarbitone 20 mg/kg** (+10 mg/kg once) → **phenytoin/fosphenytoin 20 mg/kg PE** → **lorazepam 0.05 mg/kg** → midazolam infusion or
levetiracetam 40 mg/kg.

- **Duration**: no maintenance after a single brief seizure needing one phenobarbitone load; after 72 h seizure-free stop the others one by one;
stop phenobarbitone at 1 week or discharge if examination and EEG are normal. Follow up development and hearing.

## Traps the Examiner Sets

- Jaundice in the first 24 hours is never physiological.

- Breastfeeding jaundice = early, low intake, feed more; breast-milk jaundice = late (after day 5–7), peaks 2 weeks.

- Phototherapy uses **blue** light (425–475 nm); sunlight and phenobarbitone are not treatments.

- Hypoglycaemia threshold in the ICMR workflow is **45 mg/dL**; bolus is 2 mL/kg of **10%** (not 25%) dextrose.

- In a seizing newborn, correct glucose and calcium **before** phenobarbitone; phenobarbitone is the first antiseizure drug.

## Memory Hooks & Shortcuts

*Shortcuts to lock in this article's numbers and lists. Each one only re-packages facts proven above.*

- 🧠 **'Day 1 yellow = danger' — jaundice in the first 24 hours is never physiological** — jaundice timing

- 🧠 **BReastFeeding = Bad intake, first week; breast-MILK = Much later, 2 weeks** — two breast jaundices

- 🧠 **Kramer '4-8-12-15-20' as yellow walks head to toe** — Kramer zones

- 🧠 **Glucose: '45 is the line, 2 of 10 is the bolus, 6 is the drip'** — hypoglycaemia

- 🧠 **Seizure ladder 'Sugar, Salt (calcium), then the Barb' — then phenytoin, then lorazepam** — seizures

## Rapid-Revision Cards

- Unconjugated.

- Short RBC life, low UGT, enterohepatic.

- < 24–48 h or > 2 weeks.

- Week 1, low intake; feed more.

- After day 5–7; peaks 2 wk; beta-glucuronidase.

- Face 4–6, chest 8–10, thighs 12–14, limbs 15–18, palms > 15–20.

- < 24 h, palms/soles, ABE signs.

- Blue 425–475 nm.

- < 13–14 or 2 below cut-off.

- 2 × blood volume (80–100 mL/kg).

- Sunlight, phenobarbitone, stop breastfeeding.

- At-risk only: 2, 6, 12, 24, 48, 72 h.

- < 45 mg/dL.

- Feed, recheck 1 h.

- 2 mL/kg D10 then GIR 6.

- Up by 2 to max 12 mg/kg/min.

- > 12 for 24 h or > 7 d → hydrocortisone.

- Pedalling, mouthing, eye deviation, apnoea.

- Glucose → Ca gluconate → phenobarbitone → phenytoin → lorazepam.

- 20 mg/kg (+10).

- Others after 72 h seizure-free; phenobarbitone at 1 wk/discharge.

## Sources

*Facts in this article were checked against these documents.*

- Standard Treatment Workflows: Neonatal Jaundice in Infants ≥ 35 Weeks; Neonatal Hypoglycemia; Neonatal Seizures — ICMR / Department of Health Research, MoHFW, 2020

- MSD Manual Professional: Neonatal Hyperbilirubinemia; Neonatal Hypoglycemia — Merck & Co., 2025–2026 (link)

## Test Yourself: Practice Questions

Thirty questions in NEET PG style, many of them nursery scenarios.

## Practice Questions (NEET PG pattern)

*Original questions written in the style of the exam: +4 for a correct answer, −1 for a wrong one. Every answer
was checked against the sources listed above. NEET PG papers are not published by NBEMS, so these are not past-paper questions.*

**Q1.** Most jaundice in the first days of life is

- (a) mixed

- (b) unconjugated

- (c) obstructive

- (d) conjugated

**Answer: (b)** — MSD.

**Q2.** Which does NOT contribute to physiological jaundice?

- (a) increased UGT activity

- (b) shorter red-cell life span

- (c) increased enterohepatic circulation

- (d) low UGT activity

**Answer: (a)** — UGT is deficient.

**Q3.** Jaundice noticed at 18 hours of life is

- (a) physiological

- (b) pathological

- (c) breast-milk jaundice

- (d) normal

**Answer: (b)** — First 24–48 h → pathological.

**Q4.** Physiological jaundice usually resolves within

- (a) 6 weeks

- (b) 24 hours

- (c) 3 months

- (d) about 1 week

**Answer: (d)** — MSD.

**Q5.** Breastfeeding jaundice is due to

- (a) biliary atresia

- (b) haemolysis

- (c) beta-glucuronidase in milk after day 7

- (d) low milk intake in the first week

**Answer: (d)** — Feed more often.

**Q6.** Breast-milk (human-milk) jaundice typically peaks at about

- (a) day 4

- (b) 3 months

- (c) 2 weeks

- (d) day 2

**Answer: (c)** — Starts after 5–7 days.

**Q7.** Breast-milk jaundice is linked to which enzyme in milk?

- (a) UGT

- (b) lipase

- (c) lactase

- (d) beta-glucuronidase

**Answer: (d)** — Deconjugates bilirubin.

**Q8.** The most effective light for intensive phototherapy is

- (a) white sunlight

- (b) red, 650 nm

- (c) blue, 425–475 nm

- (d) ultraviolet B

**Answer: (c)** — MSD.

**Q9.** Phototherapy is NOT useful for

- (a) ABO incompatibility

- (b) breast-milk jaundice

- (c) physiological jaundice

- (d) conjugated hyperbilirubinaemia

**Answer: (d)** — MSD.

**Q10.** Jaundice reaching the lower abdomen and thighs (Kramer zone 3) suggests bilirubin of about

- (a) 12–14 mg/dL

- (b) > 20 mg/dL

- (c) 8–10 mg/dL

- (d) 4–6 mg/dL

**Answer: (a)** — ICMR.

**Q11.** Yellow palms and soles correspond to Kramer zone

- (a) 5

- (b) 1

- (c) 3

- (d) 4

**Answer: (a)** — > 15–20 mg/dL; serious.

**Q12.** Which makes jaundice 'serious' in the ICMR workflow?

- (a) visible jaundice in the first 24 hours

- (b) jaundice at day 5 to the chest

- (c) jaundice on day 4 limited to the face

- (d) jaundice in a feeding baby on day 3

**Answer: (a)** — Also palms/soles or ABE signs.

**Q13.** Which is a risk factor for significant jaundice listed by ICMR?

- (a) birth weight 3.5 kg

- (b) gestation < 38 weeks

- (c) female sex

- (d) caesarean birth

**Answer: (b)** — Also sibling, ABO/Rh, G6PD.

**Q14.** In haemolytic jaundice under phototherapy, TSB is repeated every

- (a) 6–8 hours

- (b) 24 hours

- (c) 2 hours

- (d) 48 hours

**Answer: (a)** — 12–24 h if non-haemolytic.

**Q15.** Phototherapy can be stopped when TSB falls below

- (a) 13–14 mg/dL or 2 mg/dL below the cut-off

- (b) 20 mg/dL

- (c) the first value

- (d) 5 mg/dL

**Answer: (a)** — ICMR.

**Q16.** The volume of a double-volume exchange transfusion is about

- (a) 500 mL

- (b) the blood volume once

- (c) twice the blood volume (80–100 mL/kg each)

- (d) 10 mL/kg

**Answer: (c)** — ICMR.

**Q17.** Which is recommended in neonatal jaundice?

- (a) phenobarbitone

- (b) continue breastfeeding

- (c) sunlight exposure

- (d) stop breastfeeding

**Answer: (b)** — ICMR don'ts.

**Q18.** Under phototherapy, bilirubin should be judged by

- (a) skin colour

- (b) transcutaneous meter

- (c) serum bilirubin, not visual or TcB

- (d) urine colour

**Answer: (c)** — ICMR.

**Q19.** Which newborn does NOT need routine glucose monitoring?

- (a) preterm baby

- (b) infant of a diabetic mother

- (c) healthy term AGA baby

- (d) SGA baby

**Answer: (c)** — ICMR.

**Q20.** In the ICMR workflow, neonatal hypoglycaemia is blood glucose below

- (a) 60 mg/dL

- (b) 30 mg/dL

- (c) 45 mg/dL

- (d) 70 mg/dL

**Answer: (c)** — Confirm in lab, don't delay.

**Q21.** An asymptomatic at-risk baby has glucose 38 mg/dL. First step is

- (a) IV bolus of 25% dextrose

- (b) hydrocortisone

- (c) supervised feed and recheck in 1 hour

- (d) glucagon

**Answer: (c)** — ICMR.

**Q22.** A jittery newborn has glucose 25 mg/dL. The bolus is

- (a) 10 mL/kg normal saline

- (b) oral glucose water

- (c) 2 mL/kg of 10% dextrose IV

- (d) 5 mL/kg of 25% dextrose

**Answer: (c)** — Then GIR 6.

**Q23.** After the bolus, dextrose infusion starts at a GIR of

- (a) 20 mg/kg/min

- (b) 2 mg/kg/min

- (c) 12 mg/kg/min

- (d) 6 mg/kg/min

**Answer: (d)** — Increase by 2 up to 12.

**Q24.** Refractory hypoglycaemia is a GIR requirement above 12 mg/kg/min for 24 h or need beyond

- (a) 3 days

- (b) 7 days

- (c) 24 hours

- (d) 1 month

**Answer: (b)** — Consider drugs, refer.

**Q25.** A common cause of transient neonatal hypoglycaemia due to hyperinsulinism is

- (a) maternal hypothyroidism

- (b) physiological jaundice

- (c) breastfeeding

- (d) maternal diabetes

**Answer: (d)** — MSD.

**Q26.** Which is a subtle neonatal seizure?

- (a) sneezing

- (b) repeated lip smacking or sucking

- (c) startle to sound

- (d) hiccups

**Answer: (b)** — Also pedalling, eye deviation, apnoea.

**Q27.** In a seizing newborn with normal glucose, the next step per ICMR is

- (a) lorazepam

- (b) phenytoin

- (c) 10% calcium gluconate 2 mL/kg IV under monitoring

- (d) observe

**Answer: (c)** — Then phenobarbitone.

**Q28.** The first antiseizure drug in the ICMR neonatal workflow is

- (a) diazepam 0.5 mg/kg

- (b) phenobarbitone 20 mg/kg

- (c) phenytoin 20 mg/kg

- (d) levetiracetam

**Answer: (b)** — Extra 10 mg/kg once if needed.

**Q29.** If seizures persist after phenobarbitone, ICMR's next drug is

- (a) midazolam infusion

- (b) carbamazepine

- (c) phenytoin or fosphenytoin 20 mg/kg PE

- (d) valproate

**Answer: (c)** — Then lorazepam.

**Q30.** Phenobarbitone can be stopped

- (a) never

- (b) only after 1 year

- (c) at 1 week or discharge if examination and EEG are normal

- (d) after the first dose always

**Answer: (c)** — ICMR.

### Active Recall

From memory: explain physiological and pathological jaundice, the two breast jaundices, Kramer zones, serious jaundice and phototherapy and exchange rules; who to screen for hypoglycaemia, the cut-off and treatment steps; and the forms and ICMR drug ladder of neonatal seizures.
